Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Crosbie

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 24, 2015
Referral patterns for mediastinal staging with EBUS across a UK Lung Cancer Network: A report from the Manchester Cancer EBUS sub-groupMatthew Evison, Philip Crosbie, Julie Morris, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Prevalence of nodal metastases in lymph node stations 8 & 9 in a large UK lung cancer surgical centre without routine pre-operative EUS nodal stagingMatthew Evison, Tim Edwards, Haval Balata, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 8, 2017
Adequacy of Intraoperative Nodal Staging during Surgical Resection of NSCLC: Influencing Factors and Its Relationship to SurvivalTim Edwards, Haval Balata, Mohamed Elshafi, et al.
Clinical Medicine (London, England)|April 21, 2022
The diagnostic pathway in lung cancer patients with best supportive care decisions: are there lessons to be learnt?Jenny King, Dinakshi Shah, Kath Hewitt, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Predicting survival following surgical resection of lung cancer using clinical and pathological variables: The development and validation of the LNC-PATH scoreHaval Balata, Philip Foden, Tim Edwards, et al.
Nature Medicine|March 24, 2026
Implementation of the NHS England Lung Cancer Screening Programme over 5 yearsRichard W Lee, Arjun Nair, Haval Balata, et al.
The Lancet. Oncology|May 4, 2023
Defining the road map to a UK national lung cancer screening programmeEmma L O'Dowd, Richard W Lee, Ahsan R Akram, et al.
Nature Medicine|October 9, 2019
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapseFrancesca Chemi, Dominic G Rothwell, Nicholas McGranahan, et al.
Nature Medicine|June 5, 2020
Publisher Correction: Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapseFrancesca Chemi, Dominic G Rothwell, Nicholas McGranahan, et al.
Health Technology Assessment (Winchester, England)|March 15, 2022
Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modellingFiona J Gilbert, Scott Harris, Kenneth A Miles, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Lung Cancer (Amsterdam, Netherlands)|February 24, 2015
Referral patterns for mediastinal staging with EBUS across a UK Lung Cancer Network: A report from the Manchester Cancer EBUS sub-groupMatthew Evison, Philip Crosbie, Julie Morris, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Prevalence of nodal metastases in lymph node stations 8 & 9 in a large UK lung cancer surgical centre without routine pre-operative EUS nodal stagingMatthew Evison, Tim Edwards, Haval Balata, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 8, 2017
Adequacy of Intraoperative Nodal Staging during Surgical Resection of NSCLC: Influencing Factors and Its Relationship to SurvivalTim Edwards, Haval Balata, Mohamed Elshafi, et al.
Clinical Medicine (London, England)|April 21, 2022
The diagnostic pathway in lung cancer patients with best supportive care decisions: are there lessons to be learnt?Jenny King, Dinakshi Shah, Kath Hewitt, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Predicting survival following surgical resection of lung cancer using clinical and pathological variables: The development and validation of the LNC-PATH scoreHaval Balata, Philip Foden, Tim Edwards, et al.
Nature Medicine|March 24, 2026
Implementation of the NHS England Lung Cancer Screening Programme over 5 yearsRichard W Lee, Arjun Nair, Haval Balata, et al.
The Lancet. Oncology|May 4, 2023
Defining the road map to a UK national lung cancer screening programmeEmma L O'Dowd, Richard W Lee, Ahsan R Akram, et al.
Nature Medicine|October 9, 2019
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapseFrancesca Chemi, Dominic G Rothwell, Nicholas McGranahan, et al.
Nature Medicine|June 5, 2020
Publisher Correction: Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapseFrancesca Chemi, Dominic G Rothwell, Nicholas McGranahan, et al.
Health Technology Assessment (Winchester, England)|March 15, 2022
Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modellingFiona J Gilbert, Scott Harris, Kenneth A Miles, et al.
Pageof 4